Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
Clinical trial NCT02469090 · COMPLETED
Trial details
- NCT number
- NCT02469090
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-18
- Primary completion
- 2017-12-11
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.